U-Blot® Research Grade ZimberelimabCat. No. WA3844Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade ZimberelimabCat. No. WA3844
U-Blot® Research Grade ZiltivekimabCat. No. WA3843
U-Blot® Research Grade ZilovertamabCat. No. WA3842
U-Blot® Research Grade ZigakibartCat. No. WA3841
U-Blot® Research Grade ZifibancimigCat. No. WA3840
U-Blot® Research Grade zevontabartCat. No. WA3839
U-Blot® Research Grade ZeripatamigCat. No. WA3838
U-Blot® Research Grade ZenocutuzumabCat. No. WA3837
U-Blot® Research Grade zemocimigCat. No. WA3836
U-Blot® Research Grade zemlikafusp alfaCat. No. WA3835
U-Blot® Research Grade ZeluvalimabCat. No. WA3834
U-Blot® Research Grade ZelminemabCat. No. WA3833